- Report
- April 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
Fostair is a combination drug used in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: formoterol fumarate dihydrate, a long-acting beta-2 agonist, and beclometasone dipropionate, an inhaled corticosteroid. Fostair is used to reduce inflammation in the airways and to open them up, allowing more air to flow through. It is available in a metered-dose inhaler, a dry powder inhaler, and a nebulizer solution.
Fostair is a widely used drug in the respiratory market, with its combination of two active ingredients providing a more effective treatment than either drug alone. It is used to treat both acute and chronic respiratory conditions, and is often prescribed as a maintenance therapy to prevent exacerbations.
Companies in the Fostair market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck, and Novartis. Show Less Read more